跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CEREZYME imiglucerase-rch 400U powder for injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
CEREZYME imiglucerase-rch 400U powder for injection vial
Approved
STANDARD
CEREZYME imiglucerase-rch 400U powder for injection vial
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
e7ba2ba72dad228c
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
e7ba2ba72dad228c
Product Name
CEREZYME imiglucerase-rch 400U powder for injection vial
Artg Id
74277
Artg Name
CEREZYME imiglucerase-rch 400U powder for injection vial
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
2000-07-04
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/ad0de6f02c123187e15a4743055b43fb.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/3e31f8ca2ca1b9641c0e4745216ab481.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
e7ba2ba72dad228c
Type
Standard
Back to TGA Approvals